Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS

PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS is a federal contractor, registered under UEI SJWJDLT9K556 and CAGE code 6TVH5. It has been awarded $1,731,276,300 across 34 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

SJWJDLT9K556

CAGE Code

6TVH5

Entity Structure

U.S. Government Entity

Established

N/A

Business Classifications

U.S State Government

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The Pennsylvania Department of Drug and Alcohol Programs is a state government entity responsible for administering policies, programs, and services aimed at preventing and treating substance use disorders across Pennsylvania. Its core capabilities center on public health program management, behavio...

The Pennsylvania Department of Drug and Alcohol Programs is a state government entity responsible for administering policies, programs, and services aimed at preventing and treating substance use disorders across Pennsylvania. Its core capabilities center on public health program management, behavioral health service coordination, grant oversight, and data-driven outcome monitoring within the substance abuse treatment and recovery ecosystem. The department designs and implements evidence-based interventions, manages provider networks, and ensures compliance with state and federal regulatory frameworks for addiction services. Its technical expertise includes behavioral health information systems, performance metrics tracking, workforce training initiatives, and interagency collaboration to align clinical and social support services. No award history or agency contracting data is available to infer external federal or intergovernmental contract performance. As a state agency, it does not operate as a traditional government contractor but rather delivers services directly under state authority. Consequently, there is no documented track record of performing work for federal agencies or third-party clients through competitive procurement. The entity’s industry focus lies within state-level public health administration, specifically in the behavioral health and substance use disorder treatment domain. While no NAICS codes are associated with its contracting activity, its operational scope aligns with state-funded human services programming, including prevention education, treatment access expansion, harm reduction initiatives, and recovery support services. As a state government department headquartered in Harrisburg, Pennsylvania, it operates under the 2A entity structure, indicating it is a state-level administrative agency. It holds no federal certifications such as 8(a), HUBZone, or small business status, as it is not a commercial entity. Its geographic presence is statewide, with authority to coordinate services across county-level providers and community-based organizations. It functions as a key node in Pennsylvania’s public health infrastructure, not as a vendor in the federal contracting marketplace.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
- Unknown NAICS$1.7B100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products that align with the NIH mission to enhance health and reduce illness. A mandatory requirement for this program is a formal collaboration between the SBC and a non-profit research institution. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include U.S.-owned for-profit organizations with 500 or fewer employees. The solicitation accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two options designed to accelerate the development timeline. Funding limits vary by the awarding NIH Institute or Center, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific merit, commercial potential, and the quality of the commercialization plan. While clinical trials are generally optional, they are not accepted by specific components such as NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. Applicants must maintain active registrations in the System for Award Management (SAM) and the SBA Company Registry. Required documentation includes SF424 forms and, for clinical trials, a two-page regulatory plan. Recipients must also adhere to strict cybersecurity incident reporting requirements, notifying HHS agencies within 48 hours of any discovery.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
Solicitation PA-27-100 is a grant opportunity provided by the NIH, CDC, and FDA to support United States small business concerns in conducting research and development for the creation of commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the research toward commercialization. Eligible applicants include for-profit entities located in the U.S. with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, provided the proposed work aligns with the missions of the participating agencies. Funding limits vary by institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. Key requirements include maintaining an active SAM.gov registration with a Unique Entity Identifier and adhering to strict cybersecurity incident reporting guidelines, which require notification of breaches within 48 hours. While clinical trials are generally optional, they require a specific regulatory plan and registration on ClinicalTrials.gov, though certain institutes and FDA components will not accept clinical trial proposals under this specific notice. The application deadline is April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help United States-based small business concerns transition technology from late-stage development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including late-stage research and development, independent replication of key studies, manufacturing scale-up, and technical assistance such as regulatory strategy, intellectual property planning, and market research. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in the oversight and management of the project. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated through the NIH peer review system based on scientific and technical merit, relevance to program priorities, and commercial potential. Key requirements for applicants include maintaining active SAM registration, providing a detailed regulatory plan, and submitting a CRP progress report. It is important to note that while clinical trials are generally optional, several specific NIH components, including the NHLBI, NIAID, and NIDDK, do not accept clinical trials under this specific funding opportunity. Additionally, funding cannot be used for patent or FDA filing fees or separate Technical and Business Assistance (TABA) funding.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 6 months
View Details